Genetic contribution of MHC class II and III genes to pathogenesis of RA and PSS.
Genetic contribution of MHC class II and III genes to pathogenesis of RA and PSS.
批准号:
05670416
负责人:
TAKEUCHI Fujio
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SSCP method for genotyping HLA DR was estabilished. In RA significant increase in DRB1*0405 was observed and increase in DRB1*0401 was also shown but not *0101. DRB1*0802 was decreased significantly and was thought to be an suppressive gene. RFLP analysis of TNF and HSP-70 suggested a possibility of new RA susceptible gene in the region of TNF-HSP-70. An analysis of the association with HLA-B67 and TNF10.0 suggested that not C4AQ0 itself but a susceptible gene near the C4AQ0 would contributed to the disease. In the aspect of clinical features, assosiation of TNF10.0, HSP9.0 and DRB1*0405 with an increase in urine protein, and a decrease of C4 and CH50. No assosiation was observed with disease activity. Additionally, an association of HSP9.0kb and *0405 with conformational antibody of SSA was suggested. An association of TNF5.5 (-) with unknown ANA was also observed. In Korean RA,a significant increase in *0405 and *0401 was also shown. No increase in DR1 was observed. DRB1*0802 was als … More o decreased as was shown in Japanease. The amino acid sequence "RKRAA" on DQ molecule was not associated. The result from Japanese and Korean indicated the importance of whole conformation of DR4 as well as QRRAA sequence. In PSS,increases in DRB1*1502-DRB5*0102 haplotype and DRB1*0802 were observed in diffuse scleroderma and/or anti-Sc170 positive scleroderma. Amino acids positioning at 67-71 are similar to those of DRB1*1101 and *1104 which are reported to be increased in caucasion PSS and are assumed to be susceptible sequence. TNF 5.5 band was significantly decreased in diffuse scleroderma and a-Scl-70 positive screloderma (27.3% and 23.5% respectively). The 5.5 band show significant correlation negatively with *1502. The band also show positive association with C4AQ0 and significant negative assosiation with C4BQ0. Moreover HSP 8.5 kb band show associated with anti-centromere antibody negatively. In HLA-DQ typing, DQ6.1 was increased in diffuse scleroderma (59%) and a-Scl-70 positive scleroderma (52.4%). Our observation partialy clarified the genetic factor of MHC in RA and PSS.We think it is necessary to study the various aspects of genetic factors for clarifing the pathogenesis of collagen disease and developing the clinicaly available therapy. Less
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Takeuchi F,Nakano K,Ymada H,Hong GH,Nabeta H,Yoshida A,Matsuta K,Bannai M,Tokunaga K,Ito K: "Association of HLA-DR with Progressive systemic sclerosis in Japanese." J Rheumatol. 21. 857-863 (1994)
Takeuchi F、Nakano K、Ymada H、Hong GH、Nabeta H、Yoshida A、Matsuta K、Bannai M、Tokunaga K、Ito K:“HLA-DR 与日本进行性系统性硬化症的关联。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
竹内二士夫: "膠原病の遺伝要因" リウマチ. 35(in press). (1995)
Fushio Takeuchi:“胶原病的遗传因素”风湿病学 35(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tsuchiya N: "Detection of glycosylation abnormelity in Rheumatoid IgG using N-acetyl glucosamine-specific psathyvella velutina lectin." J Immunol. 151. 1137-1146 (1993)
Tsuchiya N:“使用 N-乙酰氨基葡萄糖特异性 psathyvella velutina 凝集素检测类风湿 IgG 中的糖基化异常。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hong GH: "Association of complement C4 and HLA DR alleles with SLE in korea" J Rheumatal. 21. 442-447 (1994)
Hong GH:“补体 C4 和 HLA DR 等位基因与韩国 SLE 的关联”J Rheumatal。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takeuchi F: "Association of HLA-DR with Progressive systemic sclerosis in Japanese. 21GC03:J Rheumatol" 21. 857-863 (1994)
Takeuchi F:“日本 HLA-DR 与进行性系统性硬化症的关联。21GC03:J Rheumatol”21. 857-863 (1994)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
The research on the clinical characters of malignant neoplasm andthe origin of the causative-gene mutation in Werner's syndrome.
-
批准号:21590755
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2009
-
负责人:TAKEUCHI Fujio
-
依托单位:
The genetic research for the ethnical differences of the susceptibility genes of rheumatic diseases in East Asia
-
批准号:17406026
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.57万
-
财政年份:2005
-
负责人:TAKEUCHI Fujio
-
依托单位:
The research for the ethnical differences of the susceptibility genes of rheumatic diseases in East Asia.
-
批准号:14406018
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.68万
-
财政年份:2002
-
负责人:TAKEUCHI Fujio
-
依托单位:
The research for the genetic factors of rheumatoid arthritis using the methods applying the polymorphism in microsatellites and the single nucleotide polymorphism
-
批准号:12670417
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2000
-
负责人:TAKEUCHI Fujio
-
依托单位:
Study of DMA and DMB as susceptibility genes of SLE, PSS and RA
-
批准号:09670470
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.79万
-
财政年份:1997
-
负责人:TAKEUCHI Fujio
-
依托单位:
Lifetime measurement of pi^+pi^- atoms to test low energy QCD predictions
-
批准号:08044098
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$4.35万
-
财政年份:1996
-
负责人:TAKEUCHI Fujio
-
依托单位:
Genetic cantribution of TAP1 and TAP2 genes to pathogenesis of RA,PSS and SLE
-
批准号:07670520
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1995
-
负责人:TAKEUCHI Fujio
-
依托单位:
A test of QCD by measuring a life-time of hadoronic atoms.
-
批准号:07454056
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.06万
-
财政年份:1995
-
负责人:TAKEUCHI Fujio
-
依托单位:
Association of HLA-DR and TAP genes with PSS in Koreans.-the basic trial
-
批准号:07044317
-
项目类别:Grant-in-Aid for International Scientific Research.
-
资助金额:$0.0万
-
财政年份:1995
-
负责人:TAKEUCHI Fujio
-
依托单位:
Study for genetical background of arthritis rheumatism on MNC clacc II and III antigens.
-
批准号:02670268
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.66万
-
财政年份:1990
-
负责人:TAKEUCHI Fujio
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于单细胞测序探讨气道上皮细胞HLA-DR分子在吸烟诱导的气道过度炎症中的作用机制
-
批准号:82370021
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:易群
-
依托单位:
肺炎克雷伯菌FimA抗原的HLA-DR限制性Th17细胞优势应答谱学特征与疾病转归相关性研究
-
批准号:CSTB2023NSCQ-MSX0024
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:赵卓
-
依托单位:
新冠病毒表位的HLA-DR限制性Th优势应答谱学特征及其与疾病转归相关性研究
-
批准号:82371787
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:赵卓
-
依托单位:
乙肝恶性转化中HLA-DR基因多态性和T细胞受体库多样性的联合作用机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:邓阳
-
依托单位:
自免疫疾病易感HLA-DR异常增强CD4介导TCR抗原识别的力学调控机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:张同同
-
依托单位:
金葡菌疫苗抗原Hla及IsdB的HLA-DR限制性Th17细胞优势表位的鉴定及其免疫保护机制研究
-
批准号:31970869
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2019
-
负责人:赵卓
-
依托单位:
HLA-DR限制性HBV表位介导慢加急性肝衰竭患者CD4+T细胞活化的机制研究
-
批准号:81900579
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:谭文婷
-
依托单位:
LAG-3调控HLA-DR基因参与帕金森病DA神经元变性的分子机制研究
-
批准号:81870992
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2018
-
负责人:徐评议
-
依托单位:
靶向CD20和HLA-DR的双特异抗体在非霍奇金淋巴瘤中的抗肿瘤研究
-
批准号:81703045
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2017
-
负责人:曾静
-
依托单位:
β2-AR/NF-κB/HLA-DR通路介导交感神经-单核细胞交互与创伤性脑损伤后感染风险增加的研究
-
批准号:81601060
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:王嘉炜
-
依托单位: